DCM
DAFNA Capital Management’s Arcturus Therapeutics ARCT Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2020
Q4 | – | Sell |
-229,652
| Closed | -$9.85M | – | 76 |
|
2020
Q3 | $9.85M | Buy |
229,652
+80,635
| +54% | +$3.46M | 3.2% | 5 |
|
2020
Q2 | $6.97M | Buy |
149,017
+96,431
| +183% | +$4.51M | 2.01% | 13 |
|
2020
Q1 | $715K | Sell |
52,586
-121,328
| -70% | -$1.65M | 0.3% | 59 |
|
2019
Q4 | $1.89M | Hold |
173,914
| – | – | 0.65% | 35 |
|
2019
Q3 | $1.79M | Buy |
173,914
+171,514
| +7,146% | +$1.76M | 0.67% | 38 |
|
2019
Q2 | $23K | Sell |
2,400
-44,855
| -95% | -$430K | 0.01% | 87 |
|
2019
Q1 | $323K | Sell |
47,255
-25,550
| -35% | -$175K | 0.14% | 71 |
|
2018
Q4 | $330K | Buy |
+72,805
| New | +$330K | 0.16% | 67 |
|
2014
Q3 | – | Sell |
-84,996
| Closed | -$1.47M | – | 60 |
|
2014
Q2 | $1.47M | Buy |
84,996
+75,375
| +783% | +$1.3M | 1.39% | 18 |
|
2014
Q1 | $175K | Buy |
+9,621
| New | +$175K | 0.15% | 45 |
|